Yujin Suk

Yujin Suk

Auto-generated profile, based on publicly available information

Yujin Suk

McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Cell Reports
Verified
Journal Article
Open access
TLTruc T. Losier
Truc T. Losier
MAMercy Akuma
Mercy Akuma
OMOlivia C. McKee-Muir
Olivia C. McKee-Muir
NLNicholas D. LeBlond
Nicholas D. LeBlond
YSYujin Suk
Yujin Suk
RRRyan C. Russell
Ryan C. Russell
The autophagy pathway is an essential facet of the innate immune response, capable of rapidly targeting intracellular bacteria. However, the initial signaling regulating autophagy induction in response to pathogens remains largely unclear. Here, we report that AMPK, an upstream activator of the autophagy pathway, is stimulated upon detection of pathogenic bacteria, before bacterial invasion. Bacterial recognition occurs through the detection of outer membrane vesicles. We found that AMPK signaling relieves mTORC1-mediated repression of the autophagy pathway in response to infection, positioning the cell for a rapid induction of autophagy. Moreover, activation of AMPK and inhibition of mTORC1 in response to bacteria is not accompanied by an induction of bulk autophagy. However, AMPK signaling is required for the selective targeting of bacteria-containing vesicles by the autophagy pathway through the activation of pro-autophagic kinase complexes. These results demonstrate a key role for AMPK signaling in coordinating the rapid autophagic response to bacteria.

4 March 2024 in Genes
Verified
Journal Article
Open access
PDF file
AMAlice Man
Alice Man
MSMatteo Di Scipio
Matteo Di Scipio
SGShan Grewal
Shan Grewal
YSYujin Suk
Yujin Suk
ETElisabetta Trinari
Elisabetta Trinari
RWRobyn Whitney
Robyn Whitney
The mechanistic target of rapamycin (mTOR) pathway serves as a master regulator of cell growth, proliferation, and survival. Upregulation of the mTOR pathway has been shown to cause malformations of cortical development, medically refractory epilepsies, and neurodevelopmental disorders, collectively described as mTORopathies. Tuberous sclerosis complex (TSC) serves as the prototypical mTORopathy. Characterized by the development of benign tumors in multiple organs, pathogenic variants in TSC1 or TSC2 disrupt the TSC protein complex, a negative regulator of the mTOR pathway. Variants in critical domains of the TSC complex, especially in the catalytic TSC2 subunit, correlate with increased disease severity. Variants in less crucial exons and non-coding regions, as well as those undetectable with conventional testing, may lead to milder phenotypes. Despite the assumption of complete penetrance, expressivity varies within families, and certain variants delay disease onset with milder neurological effects. Understanding these genotype–phenotype correlations is crucial for effective clinical management. Notably, 15% of patients have no mutation identified by conventional genetic testing, with the majority of cases postulated to be caused by somatic TSC1/TSC2 variants which present complex diagnostic challenges. Advancements in genetic testing, prenatal screening, and precision medicine hold promise for changing the diagnostic and treatment paradigm for TSC and related mTORopathies. Herein, we explore the genetic and molecular mechanisms of TSC and other mTORopathies, emphasizing contemporary genetic methods in understanding and diagnosing the condition.

18 August 2022 in STAR Protocols
Verified
Journal Article
Open access
YSYujin Suk
Yujin Suk
AKAgata Kieliszek
Agata Kieliszek
DMDaniel Mobilio
Daniel Mobilio
CVChitra Venugopal
Chitra Venugopal
Sheila SinghSheila Singh
Sheila Singh
Human neural stem cells (hNSCs) are a valuable tool in brain cancer research since they are used as a normal control for multiple assays, mainly pertaining to toxicity. Here, we present a protocol to safely and successfully derive and culture hNSCs in vitro from human embryonic brain tissue. We describe the steps to dissociate embryonic brain tissue and culture hNSCs, followed by the procedure to expand hNSCs. These cells can be used for downstream applications including RNA-seq and omics studies.

6 December 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MKMichelle M. Kameda-Smith
Michelle M. Kameda-Smith
HZHelen Zhu
Helen Zhu
ELEn-Ching Luo
En-Ching Luo
YSYujin Suk
Yujin Suk
AXAgata Xella
Agata Xella
Sheila SinghSheila Singh
Sheila Singh
Pediatric medulloblastoma (MB) is the most common solid malignant brain neoplasm, with Group 3 (G3) MB representing the most aggressive subgroup. MYC amplification is an independent poor prognostic factor in G3 MB, however, therapeutic targeting of the MYC pathway remains limited and alternative therapies for G3 MB are urgently needed. Here we show that the RNA-binding protein, Musashi-1 (MSI1) is an essential mediator of G3 MB in both MYC-overexpressing mouse models and patient-derived xenografts. MSI1 inhibition abrogates tumor initiation and significantly prolongs survival in both models. We identify binding targets of MSI1 in normal neural and G3 MB stem cells and then cross referenced these data with unbiased large-scale screens at the transcriptomic, translatomic and proteomic levels to systematically dissect its functional role. Comparative integrative multi-omic analyses of these large datasets reveal cancer-selective MSI1-bound targets sharing multiple MYC associated pathways, providing a valuable resource for context-specific therapeutic targeting of G3 MB.

24 June 2023 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
AAAshley A. Adile
Ashley A. Adile
DBDavid Bakhshinyan
David Bakhshinyan
YSYujin Suk
Yujin Suk
DUDavid Uehling
David Uehling
MSMehakpreet Saini
Mehakpreet Saini
Sheila SinghSheila Singh
Sheila Singh

13 February 2024 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
RKRakhshan Kamran
Rakhshan Kamran
LJLiam Jackman
Liam Jackman
CCCynthia Chan
Cynthia Chan
ALAnn C. Lee
Ann C. Lee
AKAleeza Kamran
Aleeza Kamran
ADAndrea S. Doria
Andrea S. Doria